Myelodysplastic Syndromes News and Research

RSS
EPO and growth factor therapy safe for anemic MDS patients

EPO and growth factor therapy safe for anemic MDS patients

Array Biopharma reports Q4 and full year 2009 financials

Array Biopharma reports Q4 and full year 2009 financials

Monoclonal antibody cancer therapy

Monoclonal antibody cancer therapy

VIDAZA (azacitidine) study reports survival benefit in higher-risk MDS extends to AML patients

VIDAZA (azacitidine) study reports survival benefit in higher-risk MDS extends to AML patients

Dacogen data presented on trial in seniors with acute myeloid leukemia

Dacogen data presented on trial in seniors with acute myeloid leukemia

Effects of stem cell source and patient age on stem cell transplantation outcomes

Effects of stem cell source and patient age on stem cell transplantation outcomes

Nplate receives positive opinion for marketing authorisation in Europe

Nplate receives positive opinion for marketing authorisation in Europe

Avoiding spleen removal for Cooley's anemia sufferers

Avoiding spleen removal for Cooley's anemia sufferers

New insights into anti-cancer effects of NSAIDs

New insights into anti-cancer effects of NSAIDs

Novel mechanism found that may boost impaired function of leukemia protein

Novel mechanism found that may boost impaired function of leukemia protein

Revlimid receives approval in Switzerland for treatment of multiple myeloma

Revlimid receives approval in Switzerland for treatment of multiple myeloma

Patients with myelodysplastic syndromes treated with Revlimid are living longer and remaining transfusion independent

Patients with myelodysplastic syndromes treated with Revlimid are living longer and remaining transfusion independent

Turning the immune system against cancer

Turning the immune system against cancer

ChemGenex Pharmaceuticals receives U.S. orphan drug designation for Ceflatonin

ChemGenex Pharmaceuticals receives U.S. orphan drug designation for Ceflatonin

Decitabine improves patient outcomes in myelodysplastic syndromes

Decitabine improves patient outcomes in myelodysplastic syndromes

Thalomid gives hope for blood cancer sufferers

Thalomid gives hope for blood cancer sufferers

Revlimid results look promising for multiple myeloma patients

Revlimid results look promising for multiple myeloma patients

Revlimid clinical data in newly diagnosed multiple myeloma presented

Revlimid clinical data in newly diagnosed multiple myeloma presented

Positive results from phase 2 trial of Telintra, drug candidate in myelodysplastic syndrome

Positive results from phase 2 trial of Telintra, drug candidate in myelodysplastic syndrome